Paul Tudor Jones Tg Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $19.2 Billion
- Q2 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 83,092 shares of TGTX stock, worth $2.02 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
83,092
Previous 154,496
46.22%
Holding current value
$2.02 Million
Previous $2.35 Million
37.08%
% of portfolio
0.01%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding TGTX
# of Institutions
298Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$333 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$277 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$163 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$88.8 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$79 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.54B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...